The Europe breast implants marketis expected to reach US$ 537.25 million in 2027 from US$ 381.67 million in 2019. The market is estimated to grow with a CAGR of 4.6% from 2020-2027.
The growth of the market is driven by the factors such as, increasing breast cancer rate in Europe and rise in breast cosmetic procedures are expected to augment the growth of the market. However, disadvantages of breast implants like rippling and scarring is likely to have negative impact on the growth of the Europe Breast Implants market in the coming years.
Breast cancer is very common in the WHO European region. As per the EUROPA DONNA report, there was incidence of 562,500 women breast cancer cases in 2018 in the WHO Europe region. It also reported that estimated number of deaths due to breast cancer in 2018 in the WHO Europe region was 150,700, and 98,735 deaths in EU-28 member states. As per the Cancer Research UK, in 2017, 54,700 new breast cancer cases were diagnosed in UK. In UK, breast cancer accounts for 15% of all new cancer cases.
The increase in breast cancer cases is due to changes in lifestyle habits, sedentary lifestyle, weight gain and obesity, increase in alcohol consumption, hormone replacement therapy (HRT) and the risk of developing breast cancer and sociological changes like increasing age at first birth and decreasing number of children born to women. As per the Health Survey for England 2017, 61.5% of women are overweight or obese.
Thus, growing prevalence of breast cancer in Europe will demand breast implants.
Furthermore, the impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. In Among all European countries, Spain, Italy, Germany, France, and UK are most affected due to increasing number of coronavirus cases and deaths associated with it. As per the worldometer, in Spain, Italy, Germany, France, UK and Netherlands, Belgium and Luxembourg the number of cases are 2,13,024; 1,89,973; 1,53,129; 1,20,804;1,38,078; 35,729; 42,797; 3,665 respective and number of deaths are also high. As per the news article, in Italy, due to Covid-19 emergency, access for thousands of cancer patients in need of chemotherapy, scans, transplants and surgery has become difficult. According to the research led by Codice Viola, charity that supports patient having pancreatic cancer found that more than 500 breast or pancreatic patients appointments for chemotherapy or radiotherapy were postponed.
Rest of Europe Breast Implants Market Revenue and Forecast to 2027 (US$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Breast Implants – Market Segmentation
ByProduct
- Silicone
- Saline
By Application
- Reconstructive Surgery
- Cosmetic Surgery
By Surface Type
- Smooth
- Textured
By Country
- UK
- Germany
- France
- Spain
- Italy
- The Netherlands
- Belgium
- Luxembourg
Company Profiles
- Mentor Worldwide Llc
- POLYTECH Health & Aesthetics Gmbh
- GroupeSebbinSas
- Gc Aesthetics Plc
- Allergan Plc
Europe Breast Implants Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 381.67 Million |
Market Size by 2027 | US$ 537.25 Million |
Global CAGR (2020 - 2027) | 4.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















